Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Customer Logins
Gustav Ando has overall responsibility for life sciences and comparative industry outlooks
Mr. Ando oversees the development of IHS Markit's global healthcare outlook analysis that focuses on market access, cost of healthcare and new treatment advances as well as coordinating its ongoing thinking on COVID-19. He heads the research and data teams that produce daily analysis, risk assessment and critical data for the pharmaceutical industry, as well as the consulting team that focuses on disease prevention, workforce and demand healthcare microsimulation models. With more than 15 years of experience in the industry, he is a regular speaker at conferences and is frequently cited by major media publications and national radio and television programs. He is the author and podium presenter of research at numerous academic conferences such as ISPOR. Mr Ando also oversees our global comparative industry group which provide critical long-term forecast perspectives across all industries around the world, as well as our specialised global constructrion group. Mr. Ando holds a postgraduate degree from the University of Uppsala, Sweden, and an undergraduate degree from the University of Durham in the United Kingdom.
Life Sciences Research & Analysis Prices of Essential COVID-19 Medicines Have Increased 4% Globally Since February 08 July 2020 Gustav Ando...
Episode 46: The impact of COVID-19 on the healthcare industry and policy decisions 12 June 2020 17:31 Gustav Ando Milena Izmirlieva As countries...
Life Sciences Research & Analysis COVID-19 treatments: No magic bullet 11 June 2020 Gustav Ando Janet Beal As communities, states, and countries...
Life Sciences US scrambles for resources in COVID-19 response 30 March 2020 Gustav Ando According to new IHS Markit data, the United States'...
Life Sciences ISPOR Europe 2018 Barcelona 12 November 2018 Gustav Ando We are at ISPOR Europe 2018 in Barcelona, Spain! We look forward to seeing...
Life Sciences Rapid changes in the global IRP environment 08 November 2018 Gustav Ando The announcement on 25 October that the US is planning...
Life Sciences Nevermore ignore the role of digital health in health decision making 22 May 2018 Gustav Ando Here at the opening of the 23rd...
Life Sciences ISPOR 2018 Baltimore 18 May 2018 Gustav Ando We are pleased to announce that we will be at ISPOR 2018, 19-23 May, in Baltimore...
Life Sciences Visit us at ISPOR 2017 Glasgow! 01 November 2017 Gustav Ando We are pleased to announce that we will be at the 20th Annual ISPOR...
Life Sciences US Healthcare Reform: The ISPOR Debate 23 May 2017 Gustav Ando Much like the Pixies, who spent the last few days playing a series...
Join our IHS Markit experts, including Chief Econo (...)
Secrets to Surviving in Volatility: Planning for s (...)
Theo Acheampong, PhD
Senior Analyst Country Risk – Sub-Saharan Africa, IHS Markit
John Anton, J.D.
Associate Director – Pricing and Purchasing, IHS Markit
Carlos Cardenas
Director, Latin America Country Risk, IHS Markit